FLT3 and acute myeloid leukemia: Approximately 30% of patients with newly diagnosed AML have mutations in the FLT3 gene, most commonly an internal tandem duplication (ITD; ~25% of cases) or point mutations in the tyrosine kinase domain (TKD; 7%–10% of cases) (9).